Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 50.90
+1.40 (2.83%)
At close: Jan 23, 2026
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 18.73 billion as of January 23, 2026. Its market cap has increased by 38.31% in one year.
Market Cap
18.73B
Enterprise Value
18.80B
Revenue
428.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
50.90
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 18.73B, an increase of 146.89%. That is a compound annual growth rate of 15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 18.73B | -2.58% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 29.92B |
| Biocytogen Pharmaceuticals (Beijing) | 29.31B |
| Genscript Biotech | 28.84B |
| InnoCare Pharma | 22.95B |
| Keymed Biosciences | 16.70B |
| Zai Lab | 15.93B |
| Guangzhou Innogen Pharmaceutical Group | 14.26B |
| Ascletis Pharma | 14.09B |